SCHEMBL14033487

SCHEMBL14033487

CC(C)[C@H]1CN(C(c2ccc(F)cc2)c2ccc(F)cc2)CCN1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.44
ACHE P22303 3/20 0.40
CYP2D6 P10635 2/20 0.37
CYP19A1 P11511 1/20 0.37
OPRM1 P35372 3/20 0.37
OPRD1 P41143 3/20 0.37
OPRK1 P41145 2/20 0.37
OPRL1 P41146 2/20 0.37
GRM2 Q14416 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
FAAH O00519 1/20 0.35
MGLL Q99685 1/20 0.35
IGF1R P08069 1/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033816 0.85 CYP2D6 (0.55) HRH3CYP2D6CYP19A1OPRM1OPRD1
SCHEMBL14034022 0.85 CYP2D6 (0.55) HRH3CYP2D6CYP19A1OPRM1OPRD1
SCHEMBL13307944 0.85 MEN1 (0.53) CYP2D6OPRM1OPRD1OPRK1OPRL1
SCHEMBL7437112 0.83 HRH3 (0.58) HRH3ACHECYP2D6CYP19A1OPRM1
SCHEMBL13304693 0.81 KCNH2 (0.52) HRH3CYP2D6CYP19A1OPRM1OPRD1
SCHEMBL14033489 0.79 OPRD1 (0.61) OPRM1OPRD1OPRK1OPRL1MEN1
SCHEMBL26673752 0.78 HRH3 (0.46) HRH3ACHECYP2D6CYP19A1OPRM1
SCHEMBL14034016 0.78 MEN1 (0.49) ACHECYP2D6OPRM1OPRD1MEN1
SCHEMBL21910596 0.77 HRH3 (0.42) HRH3ACHECYP2D6CYP19A1OPRM1
SCHEMBL25919486 0.76 OPRD1 (0.42) HRH3ACHEOPRM1OPRD1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed